Epidural Steroid Injections Could Help Avoid Surgery
By HospiMedica International staff writers Posted on 27 Jan 2015 |
For patients with lower back pain, epidural steroid injections (ESI) could reduce the need for surgery, according to a new study.
Researchers at Massachusetts General Hospital (Boston, USA) conducted a systematic review and meta-analysis of studies to determine whether ESI could have a surgery-sparing effect in patients with spinal pain. Databases searched included Cochrane, PubMed, and EMBASE. The primary analysis evaluated randomized controlled trials (RCTs) in which treatment groups received ESI and control groups underwent control injections. Secondary analyses involved RCTs comparing surgery with ESI or conservative treatment in which the operative disposition of subjects who received ESI was evaluated.
The researchers found that only those studies that there was moderate evidence that patients receiving ESI versus control treatment were less likely to undergo surgery. For studies examining surgery as a secondary outcome, there was a trend toward reduction in the need for surgery for short-term, but not long-term (at least one year) outcomes. Low-level evidence suggested that between one-third and one-half of patients considering surgery could avoid surgery with ESIs. The study was published in the February 1, 2015, issue of the Spine Journal.
“Low back pain is debilitating and costly, especially for patients not responding to conservative therapy and requiring surgery,” concluded lead author Mark Bicket, MD, and colleagues. “Epidural steroid injections may provide a small surgery-sparing effect in the short term compared with control injections, and reduce the need for surgery in some patients who would otherwise proceed to surgery.”
An ESI can help relieve pain caused by spinal stenosis, spondylosis, or disc herniation by delivering medication to the spinal nerve through the epidural space. It usually includes both a long-lasting corticosteroid (such as triamcinolone or betamethasone) and an anesthetic numbing agent (lidocaine or bupivacaine). The effects of ESI tend to be temporary, with the goal being to reduce pain so that a person may resume normal activities and a physical therapy program.
Related Links:
Massachusetts General Hospital
Researchers at Massachusetts General Hospital (Boston, USA) conducted a systematic review and meta-analysis of studies to determine whether ESI could have a surgery-sparing effect in patients with spinal pain. Databases searched included Cochrane, PubMed, and EMBASE. The primary analysis evaluated randomized controlled trials (RCTs) in which treatment groups received ESI and control groups underwent control injections. Secondary analyses involved RCTs comparing surgery with ESI or conservative treatment in which the operative disposition of subjects who received ESI was evaluated.
The researchers found that only those studies that there was moderate evidence that patients receiving ESI versus control treatment were less likely to undergo surgery. For studies examining surgery as a secondary outcome, there was a trend toward reduction in the need for surgery for short-term, but not long-term (at least one year) outcomes. Low-level evidence suggested that between one-third and one-half of patients considering surgery could avoid surgery with ESIs. The study was published in the February 1, 2015, issue of the Spine Journal.
“Low back pain is debilitating and costly, especially for patients not responding to conservative therapy and requiring surgery,” concluded lead author Mark Bicket, MD, and colleagues. “Epidural steroid injections may provide a small surgery-sparing effect in the short term compared with control injections, and reduce the need for surgery in some patients who would otherwise proceed to surgery.”
An ESI can help relieve pain caused by spinal stenosis, spondylosis, or disc herniation by delivering medication to the spinal nerve through the epidural space. It usually includes both a long-lasting corticosteroid (such as triamcinolone or betamethasone) and an anesthetic numbing agent (lidocaine or bupivacaine). The effects of ESI tend to be temporary, with the goal being to reduce pain so that a person may resume normal activities and a physical therapy program.
Related Links:
Massachusetts General Hospital
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery